息肉样脉络膜血管病变诊疗进展

doi:10.6040/j.issn.1673-3770.0.2017.543

摘要/Abstract

摘要： 息肉状脉络膜血管病变(PCV)的特点是眼底可见橘红色病灶,吲哚菁绿血管造影显示一个或多个高荧光即息肉样病变,伴或不伴有异常的分支血管网和浆液性和(或)出血性的视网膜色素上皮的脱离。PCV因其独特的临床表现及较高的发病率受到越来越多的关注。随着科学及医疗技术的进步,新的检查设备、疗法和药物被眼科界采用,使得对PCV的认识、诊断与治疗迈向了新阶段。对 PCV在诊断和治疗方面的进展进行综述。

关键词: 息肉样脉络膜血管病变, 诊断, 治疗

Abstract: Polypoid choroidal vasculopathy(PCV)is characterized by visible orange lesions on fundoscopy. Indocyan-nine green angiograph depicts one or more hyperfluorescent polypoid lesions, with or without abnormal branching vasculature, and also serous and hemorrhagic retinal pigment epithelial detachment. Because of its unique clinical features and higher incidence, increasing attention is being paid to PCV. With advances in science and medical technology, new screening devices, therapies, and drugs are being adopted, all of which has led to a new phase in the understanding, diagnosis, and treatment of PCV. This article reviews the progress of PCV in terms of its diagnosis and treatment.

Key words: Polypoidal choroidal vasculopathy, Diagnosis, Treatment

中图分类号:

R774

王仙,李颖,赵博军. 息肉样脉络膜血管病变诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 103-106.

WANG Xian, LI Ying, ZHAO Bojun. Advances in diagnosis and treatment of polypoid choroidal vasculopathy[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 103-106.

参考文献

[1] Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy(IPCV)[J]. Retina, 1990, 10(1):1-8.
[2] Lim S, Cheung CMG, Wong TY. Asian age-related macular degeneration[J]. Asia Pac J Ophthalmol, 2013, 2(1):32-41.
[3] Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics[J]. Arch Ophthalmol, 2003, 121(10):1392-1396.
[4] Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy:an angiographic discussion[J]. Eye, 2010, 24(3):483-490.
[5] Wong CW, Wong TY. Polypoidal choroidal vasculopathy in Asians[J]. J Clin Med, 2015, 4:782-821.
[6] Wong CW, Yanagi Y, Lee WK, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians[J]. Prog Retin Eye Res, 2016, 53:107-139.
[7] 颜昕,王翠,赵博军. 息肉状脉络膜血管病变的临床表现分析[J]. 山东大学耳鼻喉眼学报,2017,31(4):98-102. YAN Xin, WANG Cui, ZHAO Bojun. Clinical manifestations of polypoidal choroidal vasculopathy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(4):98-102.
[8] Li Y, You QS, Wei WB, et al. Polypoidal choroidal vasculopathy in adult chinese: the Beijing eye study[J]. Ophthalmol, 2014, 121(11):2290-2291.
[9] Koh AH, Chen LJ, et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment[J]. Retina, 2013, 33(4):686-716.
[10] Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green(ICG)as related to angiography[J]. Surv Ophthalmol, 2000, 45(1):15-27.
[11] Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review[J]. Surv Ophthalmol, 2010, 55(6): 501-515.
[12] Coppens G, Spielberg L, Leys A. Polypoidal choroidal vasculopathy,diagnosis and management[J]. Bull Soc Belge Ophtalmol, 2011(317):39-44.
[13] Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2005, 89(5): 602-607.
[14] Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography[J]. Retina, 2009, 29(1):52-59.
[15] Sato T, Kishi S, Watanabe G, et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy[J]. Retina, 2007, 27(5):589-594.
[16] De Salvo G, Vaz Pereira S, Keane PA, et al. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2014, 158(6):1228-1238.
[17] Chang YS, Kim JH, Kim JW, et al. Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in korean patients[J]. Kor J Ophthalmol, 2016, 30(3):198.
[18] 张怡,姚静,王肖华,等. 光学相干断层扫描诊断息肉状脉络膜血管病变的敏感性和特异性[J]. 南方医科大学学报,2017,37(2):165-171. ZHANG Yi, YAO Jing, WANG Xiaohua, et al. Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy [J]. J Sout Med Univ, 2017, 37(2):165-171.
[19] Tomiyasu T, Nozaki M, Yoshida M, et al. Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):324-330.
[20] Kim JY, Kwon OW, Oh HS, et al. Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy[J]. Graefes Arch Clin Exp Ophthalmo, 2016, 254(8):1505-1510.
[21] Inoue M, Balaratnasingam C, Freund KB. Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization[J]. Retina, 2015, 35(11):2265-2274.
[22] Wang M, Zhou Y, Gao SS, et al. Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):526-532.
[23] Takayama K, Ito Y, Kaneko H, et al. Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy[J]. Eye, 2017, 31(1):45-52.
[24] Wong IY, Shi X, Gangwani R, et al. One-year results of half- versus standard-dose photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy[J]. Retina, 2017. DOI: 10.1097/IAE.0000000000001614.
[25] Hikichi T. Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2018, 102(1):97-101.
[26] 杨景元,王尔茜,陈有信.光动力疗法与玻璃体腔注射抗血管内皮生长因子制剂治疗息肉样脉络膜血管病变的Meta分析[J].中华眼底病杂志,2016,32(1):73-78. YANG Jingyuan, WANG Erqian, CHEN Youxin, et al. Meta-analysis of photodynamic therapy and intravitreal injection of anti-vascular endothelial growth factor agent in the treatment of polypoid choroidal vasculopathy[J]. Chin J Ocul Fund Dis, 2016, 32(1):73-78.
[27] Koh A, Lee WK, Chen LJ, et al. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy[J]. Retina, 2012, 32(8):1453-1464.
[28] Gomi F, Sawa M, Wakabayashi T, et al. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2010, 150(1):48-54.
[29] Koh A, Lai TYY, Takahashi K, et al. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial[J]. JAMA Ophthalmol, 2017, 135(11):1206-1213.

相关文章 15

[1]	方璐, 雷玉丹, 王华. 环孢素滴眼液联合玻璃酸钠滴眼液治疗干眼临床效果的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 65-73.
[2]	雷玉丹,方璐,陈健,彭昌福. 托珠单抗治疗激素抵抗或不耐受的中重度甲状腺相关性眼病临床疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 54-67.
[3]	朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[4]	卢朝阳, 翟兆雪, 王慧康, 邵丽婷, 张宇. 新冠肺炎治疗引发糖尿病酮症酸中毒合并鼻眶脑型毛霉菌病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 90-94.
[5]	顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[6]	程卓, 梁辉, 邢鲁民. 深度学习技术在咽喉内镜应用中的研究进展及前景分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 112-119.
[7]	刘一洁,卢秀珍,吴秋欣. 外泌体在眼病发病机制和诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 135-141.
[8]	马孝宝,沈佳丽,杨军,陈建勇,朱颂欢. 水平半规管扫视波的临床意义探究[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 40-45.
[9]	刘梓琪,黄佳丽,汪李琴,陈曦,张立庆,周涵. 窄带成像内镜联合嗓音声学分析在声带白斑鉴别诊断中的价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 87-96.
[10]	刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137.
[11]	韩鑫宇,陈钢钢,李莹,周丽媛,杨捷,吴佳鑫,李育军. 双侧前庭病的非药物治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 154-159.
[12]	王晓杰,张明君,宋哲莹,崔丽梅,宋西成. 山奈酚抗癌的作用机制及研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 168-178.
[13]	刘南仙,杨泽垠,韩琳,张爱英,赵宇亮,薛静,孙怡君,邵永良. 视频脑电图在儿童复发性眩晕诊断中的意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 20-25.
[14]	许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[15]	刘玉柱,苑铁君,李波. 会厌原发神经内分泌癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 97-100.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed